{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:19:52Z","timestamp":1761167992703,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ymgme.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T02:15:23Z","timestamp":1462760123000},"page":"145-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Towards rational drug treatment of Lesch-Nyhan disease"],"prefix":"10.1016","volume":"118","author":[{"given":"Roland","family":"Seifert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2016.05.004_bb0005","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/brain\/awt202","article-title":"Lesch-Nyhan Disease International Study Grup, Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder","volume":"137","author":"Fu","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2016.05.004_bb0010","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ymgme.2014.05.012","article-title":"Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease","volume":"112","author":"Fu","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0015","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM198111053051902","article-title":"Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome","volume":"305","author":"Lloyd","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0020","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-3565(25)10390-X","article-title":"Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome","volume":"263","author":"Jinnah","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ymgme.2016.04.012","article-title":"A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease","volume":"118","author":"Khasnavis","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jnnp.39.7.656","article-title":"Double-blind clinical trial of 5-hydroxytryptophan in a case of Lesch-Nyhan syndrome","volume":"39","author":"Frith","year":"1976","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2016.05.004_bb0035","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s12913-014-0551-z","article-title":"Barriers to and facilitators to counter publication bias: thematic analysis of scholarly articles and stakeholder interviews","volume":"14","author":"Kien","year":"2014","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00210-016-1216-8","article-title":"Managing risks in drug discovery: reproducibility of published findings","volume":"389","author":"Kannt","year":"2016","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2015.10.011","article-title":"Altered histamine neurotransmission in HPRT-deficient mice","volume":"609","author":"Tschirner","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tips.2012.11.001","article-title":"Molecular and cellular analysis of human histamine receptor subtypes","volume":"34","author":"Seifert","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neubiorev.2014.03.009","article-title":"Modulation of behavior by the histaminergic system: lessons from H1R- and H2R-deficient mice","volume":"42","author":"Schneider","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymgme.2016.05.004_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2014.07.020","article-title":"Modulation of behavior by the histaminergic system: lessons from HDC-, H3R- and H4R-deficient mice","volume":"47","author":"Schneider","year":"2014","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719216300622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:22:15Z","timestamp":1761088935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719216300622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1096719216300622"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.05.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards rational drug treatment of Lesch-Nyhan disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}